Canhui Cao

1.4k total citations · 1 hit paper
55 papers, 821 citations indexed

About

Canhui Cao is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Canhui Cao has authored 55 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Reproductive Medicine and 10 papers in Oncology. Recurrent topics in Canhui Cao's work include Cancer-related molecular mechanisms research (8 papers), Cervical Cancer and HPV Research (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Canhui Cao is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Cervical Cancer and HPV Research (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Canhui Cao collaborates with scholars based in China, Hong Kong and Vietnam. Canhui Cao's co-authors include Peng Wu, Ding Ma, Qinglei Gao, Ji Wang, Mengchen Li, Xiaoxue Zhang, Jiahong Tan, Shitong Lin, Wenqian Li and Wenhua Zhi and has published in prestigious journals such as Nature Communications, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Canhui Cao

50 papers receiving 806 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in cervical cancer: current insights and future directions

2024 34 citations Canhui Cao, Peng Wu et al. Cancer Communications profile →

Peers

Countries citing papers authored by Canhui Cao

Since Specialization

Citations

This map shows the geographic impact of Canhui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canhui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canhui Cao more than expected).

Fields of papers citing papers by Canhui Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Canhui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canhui Cao. The network helps show where Canhui Cao may publish in the future.

Co-authorship network of co-authors of Canhui Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Canhui Cao. A scholar is included among the top collaborators of Canhui Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Canhui Cao. Canhui Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recent Advances of Trained immunity in Macrophages 2025 ·International Journal of Biological Sciences ·Peizhi Li, Manman Liu, Yakun Liu, Jing Guo, Jiajia Jiang, Guan‐Bang Wang, Canhui Cao, Xinru Wang, Junxing Qu, Zhiheng Sun	1
2	The dual role of taurine in cancer and immune metabolism 2025 ·Trends in Endocrinology and Metabolism ·(unknown), Yu Yang, Canhui Cao	0
3	HPV Integration: Moving From Carcinogenesis Mechanisms to Clinical Applications 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Canhui Cao	0
4	Neuron–tumor crosstalk fuels small cell lung cancer 2025 ·Trends in Pharmacological Sciences ·Canhui Cao	0
5	Advances in cervical cancer: current insights and future directions breakdown → 2024 ·Cancer Communications ·(unknown), Canhui Cao, Peng Wu, Xiaoyuan Huang, Ding Ma	34
6	Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome 2024 ·Journal of Ovarian Research ·(unknown), (unknown), Baoying Liao, Lin Fu, (unknown), Canhui Cao, (unknown), Tianliu Peng, (unknown), Rong Li	9
7	Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA‐mutant cervical carcinoma via the PI3K/AKT pathway 2023 ·Journal of Medical Virology ·Wei Ye, Shitong Lin, Wenhua Zhi, (unknown), Binghan Liu, Ting Peng, (unknown), Wencheng Ding, Canhui Cao, Peng Wu	14
8	Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis 2023 ·Journal of Ovarian Research ·Wenjian Gong, Ruidi Yu, Canhui Cao, Yong Fang, (unknown), Qinglei Gao	4
9	A novel cuproptosis-related gene signature for overall survival prediction in uterine corpus endometrial carcinoma (UCEC) 2023 ·Heliyon ·Shitong Lin, (unknown), Binghan Liu, Lingling Zheng, Canhui Cao, Peng Wu, Wencheng Ding, Fang Ren	4
10	Single‐cell transcriptome analysis of the mouse and primate ovaries reveals oocyte‐specific expression patterns of risk genes in ovarian aging 2023 ·SHILAP Revista de lepidopterología ·Wei Ye, (unknown), Xiaoyu Liu, Shitong Lin, (unknown), Ping Zhou, He Liu, Peng Wu, Yang Yu, Canhui Cao	5
11	Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma 2023 ·EBioMedicine ·Shitong Lin, (unknown), Canhui Cao, (unknown), (unknown), Binghan Liu, (unknown), Ting Peng, Wenhua Zhi, (unknown), Wencheng Ding, Fang Ren, (unknown), Guoliang Li, Peng Wu	22
12	Ginsenoside Rb1 inhibits oxidative stress-induced ovarian granulosa cell injury through Akt-FoxO1 interaction 2022 ·Science China Life Sciences ·Ping Zhou, (unknown), Zi Yang, Canhui Cao, Hongcui Zhao, (unknown), (unknown), (unknown), Tianliu Peng, D. H. Sun, (unknown), Rong Li, Yang Yu	27
13	APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma 2022 ·Heliyon ·Ting Peng, Binghan Liu, Shitong Lin, Canhui Cao, Ping Wu, Wenhua Zhi, (unknown), (unknown), Lingli Gui, Wencheng Ding	4
14	Key Role of MCUR1 in Malignant Progression of Breast Cancer 2021 ·OncoTargets and Therapy ·Peipei Gao, Ting Peng, Shitong Lin, Wenhua Zhi, Canhui Cao, Ping Wu, Ling Xi, Peng Wu, Yang Qin, Wencheng Ding	5
15	The effects of uterine manipulators in minimally invasive hysterectomy for endometrial cancer: A systematic review and meta-analysis 2020 ·European Journal of Surgical Oncology ·Yifan Meng, Yan Liu, Shitong Lin, Canhui Cao, Ping Wu, Peipei Gao, Wenhua Zhi, Ting Peng, Lingli Gui, Peng Wu	18
16	LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype 2020 ·Frontiers in Oncology ·Canhui Cao, Shitong Lin, Wenhua Zhi, (unknown), Yifan Meng, Ping Wu, Peipei Gao, Juncheng Wei, Peng Wu	27
17	Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma 2020 ·Cancer Cell International ·Shitong Lin, Yifan Meng, Canhui Cao, Ping Wu, Peipei Gao, Wenhua Zhi, Ting Peng, Peng Wu	6
18	Immune checkpoint inhibitors in the treatment of virus-associated cancers 2019 ·Journal of Hematology & Oncology ·Peipei Gao, (unknown), Canhui Cao, Yifan Meng, Ping Wu, Wenhua Zhi, Shitong Lin, Juncheng Wei, Xiaoyuan Huang, Ling Xi, Gang Chen, Junbo Hu, Ding Ma, Peng Wu	46
19	Clinical Value of Combining ¹⁸F-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma 2018 ·Journal of Cancer ·(unknown), Wenhua Zhi, (unknown), (unknown), Ling Wang, Yifan Meng, Canhui Cao, Junbo Hu, Peng Wu	5
20	C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation 2018 ·Nature Communications ·Dan Liu, Xiaoxue Zhang, Mengchen Li, Canhui Cao, Dongyi Wan, Bixin Xi, Jiahong Tan, Ji Wang, Zongyuan Yang, Xinxia Feng, Fei Ye, Gang Chen, Peng Wu, Ling Xi, Hui Wang, Jianfeng Zhou, Zuo‐Hua Feng, Ding Ma, Qinglei Gao	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact